decreased trabecular bone volume_Ciita<tm1Wrth>/Ciita<tm1Wrth>

http://metadb.riken.jp/0010879I129P2OlaHsdC57BL6Ciitatm1WrthCiitatm1WrthCiitatm1Wrth

decreased trabecular bone volume_Ciita<tm1Wrth>/Ciita<tm1Wrth>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• class II transactivator
  http://metadb.riken.jp/db/mgi_rdf/MGI:108445

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ciita<tm1Wrth>/Ciita<tm1Wrth>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ciita<tm1Wrth>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased trabecular bone volume
  http://purl.obolibrary.org/obo/MP_0010879

文献

http://purl.org/net/cito/citesAsAuthority

• Elisa. Benasciutti, et.al., MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity., Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014, 29
  http://rdf.ncbi.nlm.nih.gov/pubmed/24038328